ducovest

FHI:CA:TSX-CI Health Care Giants Covered Call ETF Common Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 11.77

Change

0.00 (0.00)%

Market Cap

CAD 0.08B

Volume

1.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.63 (+1.82%)

 CAD 2.36B
ZWU:CA BMO Covered Call Utilities ETF

-0.10 (-1.00%)

 CAD 1.75B
XIT:CA iShares S&P/TSX Capped Informa..

+0.04 (+0.08%)

 CAD 0.65B
TXF:CA First Asset Tech Giants Covere..

+0.33 (+1.65%)

 CAD 0.60B
XHC:CA iShares Global Healthcare (CAD..

+0.30 (+0.43%)

 CAD 0.58B
HTA:CA Tech Achievers Growth & Income..

+0.34 (+1.98%)

 CAD 0.57B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.14 (-0.73%)

 CAD 0.41B
HHL:CA Harvest Healthcare Leaders Inc..

+0.03 (+0.31%)

 CAD 0.33B
CWW:CA iShares Global Water Common Cl..

+0.47 (+0.86%)

 CAD 0.32B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.05 (-0.21%)

 CAD 0.32B

ETFs Containing FHI:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.52% 27% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.52% 23% F 40% F
Trailing 12 Months  
Capital Gain 4.62% 33% F 49% F
Dividend Return 4.85% 84% B 73% C
Total Return 9.47% 40% F 55% F
Trailing 5 Years  
Capital Gain 14.61% 34% F 52% F
Dividend Return 29.44% 93% A 95% A
Total Return 44.04% 47% F 63% D
Average Annual (5 Year Horizon)  
Capital Gain 2.75% 29% F 55% F
Dividend Return 8.62% 43% F 68% D+
Total Return 5.86% 94% A 97% N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.05% 80% B- 72% C
Risk Adjusted Return 95.18% 94% A 98% N/A
Market Capitalization 0.08B 46% F 33% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.